Tumor-associated calcium-signal transducer 2 (TACSTD2) is highly expressed in uEVs of patients with bladder cancer and was proposed as a biomarker (Chen et al., 2012). This evidence concerns the gene TACSTD2 and urinary bladder carcinoma.